Maxim Group Cuts Sucampo Pharmaceuticals (SCMP); Liqtech International (NYSEAMERICAN:LIQT) Shorts Up By 38.19%

Liqtech International Incorporated (NYSEAMERICAN:LIQT) had an increase of 38.19% in short interest. LIQT’s SI was 199,000 shares in December as released by FINRA. Its up 38.19% from 144,000 shares previously. With 153,300 avg volume, 1 days are for Liqtech International Incorporated (NYSEAMERICAN:LIQT)’s short sellers to cover LIQT’s short positions. The stock decreased 3.11% or $0.014 during the last trading session, reaching $0.436. About 26,532 shares traded. LiqTech International, Inc. (NYSEAMERICAN:LIQT) has declined 54.19% since December 26, 2016 and is downtrending. It has underperformed by 70.89% the S&P500.

Among 13 analysts covering Sucampo Pharma (NASDAQ:SCMP), 10 have Buy rating, 0 Sell and 3 Hold. Therefore 77% are positive. Sucampo Pharma has $43 highest and $11.0 lowest target. $23.65’s average target is 31.94% above currents $17.925 stock price. Sucampo Pharma had 39 analyst reports since August 6, 2015 according to SRatingsIntel. UBS initiated Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) rating on Tuesday, February 9. UBS has “Buy” rating and $20 target. The stock of Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) has “Buy” rating given on Tuesday, August 1 by Mizuho. The firm has “Buy” rating by Roth Capital given on Thursday, August 3. As per Wednesday, October 18, the company rating was maintained by Jefferies. The rating was downgraded by Mizuho on Tuesday, October 3 to “Neutral”. As per Wednesday, November 1, the company rating was maintained by Mizuho. The rating was maintained by Mizuho on Friday, November 13 with “Neutral”. H.C. Wainwright initiated the stock with “Buy” rating in Monday, August 24 report. The stock has “Neutral” rating by Mizuho on Monday, January 18. The company was maintained on Friday, December 8 by Mizuho.

The stock increased 5.44% or $0.925 during the last trading session, reaching $17.925. About 13.08 million shares traded or 1023.06% up from the average. Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) has declined 5.30% since December 26, 2016 and is downtrending. It has underperformed by 22.00% the S&P500.

Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing, identifying, acquiring, and marketing medicines that meet unmet medical needs, primarily in gastroenterology, ophthalmology, and oncology-related disorders in the United States, Japan, Switzerland, and internationally. The company has market cap of $831.89 million. The companyÂ’s marketed product includes AMITIZA , a ClC-2 chloride channel activator for the treatment of chronic idiopathic constipation (CIC) in adults, irritable bowel syndrome with constipation in adult women (IBS-C), and opioid-induced constipation (OIC)in patients with chronic non-cancer related pain; and RESCULA (unoprostone isopropyl), a big potassium channel activator for the treatment of glaucoma and ocular hypertension. It currently has negative earnings. The Company’s product candidates in clinical development stage comprise Lubiprostone that is in Phase III clinical trials for the treatment of pediatric functional constipation and (IBS-C); and completed Phase III clinical trials for the treatment of (CIC) in adults, IBS-C in adult women, and OIC in patients with chronic non-cancer pain, as well as CPP-1X/sulindac combination product, which has completed Phase III clinical trials for the treatment of familial adenomatous polyposis.

Investors sentiment increased to 1.65 in 2017 Q3. Its up 0.32, from 1.33 in 2017Q2. It improved, as 14 investors sold Sucampo Pharmaceuticals, Inc. shares while 40 reduced holdings. 31 funds opened positions while 58 raised stakes. 29.83 million shares or 20.72% more from 24.71 million shares in 2017Q2 were reported. Ls Invest Llc stated it has 6,604 shares or 0% of all its holdings. Metropolitan Life Company accumulated 17,635 shares. Ser Automobile Association holds 60,800 shares. Alliancebernstein Lp accumulated 38,362 shares or 0% of the stock. The Switzerland-based Credit Suisse Ag has invested 0% in Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP). Malaga Cove Cap Limited Liability Com accumulated 84,241 shares. Arizona State Retirement Systems holds 13,000 shares or 0% of its portfolio. Proshare Ltd Co owns 28,371 shares for 0% of their portfolio. Stevens Mgmt Limited Partnership reported 34,075 shares or 0.01% of all its holdings. Commercial Bank Of America De, a North Carolina-based fund reported 110,049 shares. Fifth Third Comml Bank stated it has 0% in Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP). Hightower Advsr Lc has 119,847 shares. Engineers Gate Manager Lp invested in 0.06% or 56,030 shares. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Invest Mngmt holds 0.01% or 71,700 shares in its portfolio. Farmers Merchants Inc holds 0% or 529 shares.

Analysts await Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) to report earnings on March, 14. They expect $0.34 EPS, down 50.00% or $0.34 from last year’s $0.68 per share. SCMP’s profit will be $15.78M for 13.18 P/E if the $0.34 EPS becomes a reality. After $0.27 actual EPS reported by Sucampo Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 25.93% EPS growth.

Since September 11, 2017, it had 0 insider purchases, and 3 insider sales for $24.83 million activity. Another trade for 1.00 million shares valued at $12.00M was made by Ueno Ryuji on Monday, September 11. $825,000 worth of Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) was sold by Kiener Peter A. Kuno Sachiko sold $12.00 million worth of Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) on Monday, September 11.

LiqTech International, Inc., a clean technology company, provides technologies for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company has market cap of $19.28 million. The firm makes and sells ceramic silicon carbide membranes for liquid filtration under the LiqTech, Cometas, and Provital brand names, which are used for the filtration of produced water, pre-filtration of reverse osmosis drinking water, industrial applications, producing clean drinking water, and pool and spa water. It currently has negative earnings. It also offers diesel particulate filters for exhaust emission control solutions to the verified retrofit and the original equipment maker market; and kiln furniture for the refractory industry to support ceramics that create additional space to maximize the number of items for each firing.